Department of Anesthesiology and Pain Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Korean J Anesthesiol. 2024 Aug;77(4):455-467. doi: 10.4097/kja.24089. Epub 2024 May 7.
Ibuprofen and acetaminophen are widely used as adjuvant analgesics for postoperative pain. This meta-analysis compared the effects of intravenous (IV) ibuprofen and acetaminophen on postoperative opioid consumption and pain intensity after general anesthesia.
PubMed/MEDLINE, EMBASE, and Cochrane Library databases were searched to identify relevant studies published up to May 2023. Randomized controlled trials comparing the effects of perioperative IV ibuprofen and acetaminophen on postoperative opioid consumption and pain after general anesthesia were included in the meta-analysis and trial sequential analysis (TSA).
Eight studies with 494 participants were included. Compared to IV acetaminophen, IV ibuprofen significantly reduced 24 h opioid consumption, presented as morphine equivalents (mean difference [MD]: -6.01 mg, 95% CI [-8.60, -3.42], P < 0.00001, I2 = 55%), and pain scores (on a scale of 0-10) at 4-6 h (MD: -0.83, 95% CI [-1.29, -0.37], P = 0.0004, I2 = 65%) and 12 h (MD: -0.38, 95% CI [-0.68, -0.08], P = 0.01, I2 = 11%) postoperatively. These results were statistically significant in TSA. Pain scores at 24 h postoperatively and side effects were not significantly different between the two groups in the meta-analysis, and TSA revealed that the sample size was too small to adequately evaluate the effects, requiring further studies for conclusive results.
Perioperative IV ibuprofen reduced 24 h opioid consumption and pain severity up to 12 h postoperatively compared to acetaminophen. Additional research is required to assess pain intensity beyond 12 h and side effects.
布洛芬和对乙酰氨基酚被广泛用作术后疼痛的辅助镇痛药。本荟萃分析比较了静脉注射(IV)布洛芬和对乙酰氨基酚对全麻后阿片类药物消耗和疼痛强度的影响。
检索 PubMed/MEDLINE、EMBASE 和 Cochrane 图书馆数据库,以确定截至 2023 年 5 月发表的相关研究。将比较围手术期 IV 布洛芬和对乙酰氨基酚对全麻后阿片类药物消耗和疼痛影响的随机对照试验纳入荟萃分析和试验序贯分析(TSA)。
纳入了 8 项研究,共 494 名参与者。与 IV 对乙酰氨基酚相比,IV 布洛芬显著减少了 24 小时阿片类药物消耗,表现为吗啡当量(平均差异 [MD]:-6.01mg,95%CI [-8.60,-3.42],P<0.00001,I2=55%)和 4-6 小时(MD:-0.83,95%CI [-1.29,-0.37],P=0.0004,I2=65%)和 12 小时(MD:-0.38,95%CI [-0.68,-0.08],P=0.01,I2=11%)的疼痛评分。TSA 显示这些结果具有统计学意义。荟萃分析中,两组术后 24 小时疼痛评分和不良反应无显著差异,TSA 显示样本量太小,无法充分评估效果,需要进一步研究以得出结论。
与对乙酰氨基酚相比,围手术期 IV 布洛芬可减少 24 小时阿片类药物消耗和术后 12 小时内的疼痛严重程度。需要进一步研究以评估 12 小时后疼痛强度和不良反应。